Kyowa Kirin Executive and Leadership Team

Shinichiro Kato, the President, CSO at Kyowa Kirin, drives the company's strategic direction and corporate social responsibility initiatives. Kato's leadership focuses on advancing Kyowa Kirin's global mission to improve patient lives through innovative pharmaceutical solutions. This executive guides the integration of sustainability and ethical practices into core business operations, ensuring long-term value creation for stakeholders and society. The role involves fostering a culture of innovation and accountability across all divisions, particularly in the development of antibody-based therapies. By championing corporate social responsibility, Shinichiro Kato reinforces Kyowa Kirin's commitment to addressing critical health needs in areas such as Nephrology, Oncology, and Neurology. This strategic oversight ensures that the company's growth is aligned with its ethical imperatives and societal impact goals.

Takaaki Uochi, the President & General Manager at Kyowa Kirin, directs overall business operations and strategic growth initiatives. Uochi's leadership is pivotal in advancing Kyowa Kirin's position as a global specialty pharmaceutical leader, focusing on antibody research and engineering. This executive oversees the execution of corporate strategies across various regions, ensuring alignment with the company's mission to address unmet medical needs. The role involves driving operational excellence and fostering innovation within therapeutic areas such as Nephrology, Oncology, and Neurology. By guiding the company's general management, Takaaki Uochi ensures that Kyowa Kirin effectively navigates market dynamics and expands its impact on global health. This comprehensive oversight supports the company's commitment to delivering life-changing treatments to patients.

Steven Schaefer, the President, Kyowa Kirin Region (Kkna, North America) at Kyowa Kirin, leads the company's strategic operations and market development within North America. Schaefer's executive oversight drives the expansion of Kyowa Kirin's innovative pharmaceutical products and therapeutic solutions across the United States and Canada. This leadership role focuses on enhancing market penetration and patient access to critical treatments in areas including Oncology, Immunology/Allergy, and Neurology. By directing regional initiatives, Steven Schaefer ensures that Kyowa Kirin's commitment to addressing unmet medical needs is effectively realized within the North American healthcare landscape. The emphasis is on building strong market presence and fostering collaborations that advance patient care and scientific progress in the region.

John Alexander, the Strategy Senior Director, Information Technology & Governance, The Office of Chief of Staff & Chief Information Officer at Kyowa Kirin, directs strategic IT initiatives and governance frameworks. This leadership role ensures the alignment of technology infrastructure with the company's overarching business objectives, particularly in supporting antibody research and engineering efforts. Alexander oversees the integration of advanced IT solutions to enhance operational efficiency and data security across global operations. The focus remains on optimizing information systems to support the company's mission in Nephrology, Oncology, Immunology/Allergy, and Neurology therapeutic areas. By establishing robust governance, John Alexander ensures compliance and risk mitigation, directly contributing to the reliable execution of Kyowa Kirin's pharmaceutical development pipeline and market strategies. This position demands a deep understanding of both technological landscapes and the specific needs of a specialty pharmaceutical organization.

Kristen Sickle, the Chief of Staff To Senior Vice President. Head of Strategic Initiatives, North America Medical Affairs at Kyowa Kirin, spearheads critical strategic initiatives within the North American medical affairs division. Sickle's responsibilities include enhancing the operational effectiveness of medical affairs teams, ensuring seamless execution of strategies that support patient access to innovative therapies. This role involves close collaboration with senior leadership to identify and implement key projects that advance Kyowa Kirin's therapeutic goals in Oncology, Immunology/Allergy, and Neurology. By driving strategic initiatives, Kristen Sickle ensures that medical affairs activities are optimally aligned with the company's broader objectives for patient care and scientific advancement in the North American market. The focus is on translating strategic plans into tangible outcomes that benefit patients and healthcare providers.

Jean Compton, the Senior Analyst, Chief Marketing Officer (Contract Manufacturing) SCM at Kyowa Kirin, provides critical analytical support for supply chain management, particularly concerning contract manufacturing operations. Compton's role involves optimizing the supply chain to ensure the efficient and reliable production of pharmaceutical products, supporting Kyowa Kirin's global reach. This involves detailed analysis of SCM processes to identify areas for improvement in cost-effectiveness and delivery timelines. The focus is on enhancing the contract manufacturing aspect of the supply chain, ensuring that external manufacturing partners meet stringent quality and production standards. By delivering insightful analysis, Jean Compton contributes to the robust operational framework that underpins Kyowa Kirin's ability to deliver essential medicines across its key therapeutic areas, including Nephrology and Oncology.

Chizu Sato, the Head of Global Clinical Operations Chief of Staff at Kyowa Kirin, provides essential operational support and strategic coordination for global clinical operations. Sato's leadership ensures that clinical trials are conducted efficiently and effectively, adhering to the highest standards of quality and regulatory compliance. This role involves streamlining processes and enhancing communication across international clinical teams, facilitating the advancement of Kyowa Kirin's pipeline in critical areas like Oncology, Immunology/Allergy, and Neurology. By managing key operational aspects, Chizu Sato directly supports the timely execution of clinical development programs, crucial for bringing innovative antibody-based therapies to patients worldwide. The focus is on optimizing resource allocation and operational workflows to accelerate drug development timelines and ensure data integrity.